Psychedelics Today

A gathering with PSYCA, Anne Philippi, The New Health Institute; Joe Moore of Psychedelics Today; and Myriam Barthes, Journey Clinical. MC’d by Marissa Feinberg. More details coming soon! At a moment when companies are navigating FDA pathways, mental health providers are anticipating more treatment options nationwide, and cons...

A North Carolina coalition pushes a $5.4 million research bill for MDMA, psilocybin, and ibogaine. New Hampshire nears approval of a clinical ibogaine bill as psilocybin reform stalls. Illinois weighs psilocybin legalization alongside a new veteran suicide prevention program.

The post

Mike Finoia is a comedian based out of NYC. He is a writer/producer for TruTV’s Impractical Jokers, and he also tours with the guys on their national arena tour. Mike hosts Saturday Night Shakedown on SiriusXM’s Grateful Dead Channel, where he blends music, storytelling, and fan culture. His debut comedy special, Don’t Let Me Down, received […]

The post

Federal psychedelic policy in 2026 splits in two directions. Lawmakers and military officials are building clinical infrastructure for experimental therapeutics, while enforcement agencies freeze access and criminalize new compounds. The House Armed Services Committee is directing the Pentagon to investigate psilocybin pathways for service members, the VA is preparing for MDM...

Safar founder Sabba Nazhand watched the mental health system fail his mother, then himself. He argues AI's place is beside the therapist, extending care into the gaps between sessions, and names the risks builders have to get right.

The post